CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increased funding and public-private investments
4.1.2. Technological advancements in disease diagnostics
4.1.3. Rising incidence of infectious diseases and growing outbreaks of epidemics
4.2. Market Restraints & Challenges
4.2.1. Unfavourable regulatory scenario
4.2.2. Limited reimbursement policies for microbiology testing procedures
4.2.3. Operational barriers related to using diagnostic tests.
4.2.4. Sales of microbiology related products.
4.3. Market Opportunities
4.3.1. Improving healthcare infrastructure across the emerging economies
4.3.2. Increasing funding for research
CHAPTER 5. GLOBAL MICROBIOLOGY TESTING MARKET – BY PRODUCT
5.1 Instruments
5.1.1. Laboratory Instruments
5.1.1.1. Incubator
5.1.1.2. Petri Dish Fillers
5.1.1.3. Microbial Air Samplers
5.1.1.4. Autoclave Sterilizers
5.1.1.5. Bacterial Colony Counters
5.1.1.6. Anaerobic Culture Systems
5.1.1.7. Gram Stainers
5.1.1.8. Blood Culture Systems
5.1.1.9. Microbial Culture Systems
5.1.1.10. Others
5.1.2 Microbiology Analyzers
5.1.2.1. Mass Spectrometers
5.1.2.2. Microscopes
5.1.2.3. Molecular Diagnostic Instruments
5.2.Reagents
5.2.1. Pathogen-Specific Kits
5.2.2. General Reagents
CHAPTER 6. GLOBAL MICROBIOLOGY TESTING MARKET – BY DISEASE
AREA
6.1. Respiratory Diseases
6.2. Bloodstream Infections
6.3. Gastrointestinal Diseases
6.4. Sexually Transmitted Diseases
6.5. Urinary Tract Infections
6.6. Periodontal Diseases
6.7. Others
CHAPTER 7. GLOBAL MICROBIOLOGY TESTING MARKET – BY APPLICATION
7.1. Pharmaceutical Applications
7.2. Clinical Applications
7.3. Food Testing Applications
7.4. Cosmetic Applications
7.5. Environmental Applications
7.6. Others
CHAPTER 8. GLOBAL MICROBIOLOGY TESTING MARKET – BY END-USER
8.1. Hospitals & Diagnostic Centers
8.2. Custom Lab Service Providers
8.3. Academic & Research Institutes
CHAPTER 9. GLOBAL MICROBIOLOGY TESTING MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL MICROBIOLOGY TESTING MARKET - COMPANY
PROFILES
10.1. Biomérieux SA
10.2. Danaher Corporation
10.3. Abbott Laboratories
10.4. Becton, Dickinson and Company
10.5. Hologic, Inc.
10.6. Bruker Corporation
10.7. Roche Diagnostics
10.8. Bio-Rad Laboratories Inc.
10.9. Thermo Fisher Scientific
10.10. Qiagen N.V.
10.11. Agilent Technologies
10.12. Shimadzu Corporation
10.13. Merck KGaA
10.14. 3M Company
10.15. Neogen Corporation
CHAPTER 11. GLOBAL MICROBIOLOGY TESTING MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
